Citations

Clear

1410 citation(s) found for "Wu, Christina".

Perinatal oxygen in the developing lung
Vogel, Elizabeth R. , Britt, Rodney D. , Trinidad, Mari Charisse, Faksh, Arij , Martin, Richard J. , MacFarlane, Peter M. , Prakash, Y. S. , Pabelick, Christina M. , Prakash, Y S , Vogel, Elizabeth R

Mayo Clinic

Canadian Journal of Physiology and Pharmacology | December 9, 2014 | Volume: 93 | Issue: 2 | Pages: 119-127

10.1139/cjpp-2014-0387 | PMID 25594569 Get It

Lung diseases, such as bronchopulmonary dysplasia (BPD), wheezing, and asthma, remain significant causes of morbidity and mortality in the pediatric population, particularly in the setting of premature birth. Pulmonary outcomes in these infants are highly influenced by perinatal exposures including prenatal inflammation, postnatal intensive care unit interventions, and environmental agents. Here, there is strong evidence that perinatal supplemental oxygen administration has significant effects on pulmonary development and health. This is of particular importance in the preterm lung, where premature exposure to room air represents a hyperoxic insult that may cause harm to a lung primed to develop in a hypoxic environment. Preterm infants are also subject to increased episodes of hypoxia, which may also result in pulmonary damage and disease. Here, we summarize the current understanding of the effects of oxygen on the developing lung and how low vs. high oxygen may predispose to pulmonary disease that may extend even into adulthood. Better understanding of the underlying mechanisms will help lead to improved care and outcomes in this vulnerable population.
Establishment of the Cancer Prevention Study II Nutrition Cohort Colorectal Tissue Repository
Deka, Anusila , Cicek, Mine , Farris, Alton B. , Gaudet, Mia M. , Jacobs, Eric J. , Newton, Christina C. , Patel, Alpa V. , Thibodeau, Stephen N. , Tillmans, Lori S. , Gapstur, Susan M. , Tillmans, Lori, Campbell, Peter T. , Briggs, Peter , Teras, Lauren R. , Farris, Alton B

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | December 3, 2014 | Volume: 23 | Issue: 12 | Pages: 2694-2702

10.1158/1055-9965.epi-14-0541 | PMID 25472679 Get It

Abstract Background: To better understand colorectal cancer etiology and prognosis, archived surgical tissues were collected from Cancer Prevention Study II (CPS-II) Nutrition Cohort participants who were diagnosed with colorectal cancer. Herein, the methodology for this collection is described to help inform other efforts to collect tissues. Methods: The main components to accruing tissue were: (i) obtaining consent from participants or next-of-kin; (ii) contacting hospitals to request materials; and (iii) pathology review and laboratory processing. Results: In CPS-II, we identified 3,643 participants diagnosed with colorectal cancer between 1992/1993 and 2009. Of these, tissue could not be sought from cases verified through state cancer registry linkage (N = 1,622), because of insufficient information on tissue location. We sought tissue from the 2,021 cases verified using medical records, and received tissue from 882. When hospitals were contacted within 10 years of diagnosis, we received 87% of tissue materials; beyond that 10-year mark, we received 32%. Compared with the 2,761 colorectal cancer cases without tissue, the 882 cases with tissue were more likely to be alive, diagnosed more recently during follow-up, and had less-advanced staged disease. Cases with and without tissues were similar with respect to age at diagnosis, smoking, body mass index, physical activity, and other epidemiologic factors. Conclusions: Some of the most important elements in forming a tissue repository included having the cases' hospital contact and surgical accession information as well as contacting patients/next-of-kin and hospitals within 10 years of surgery. Impact: This tissue repository will serve as an important resource for colorectal cancer studies. See all the articles in this CEBP Focus section, “Biomarkers, Biospecimens, and New Technologies in Molecular Epidemiology.” Cancer Epidemiol Biomarkers Prev; 23(12); 2694–702. ©2014 AACR.
Hyperoxia-induced changes in estradiol metabolism in postnatal airway smooth muscle
Martin, Yvette N. , Manlove, L., Dong, Jie , Carey, William A., Pandya, Hitesh , Martin, Richard J. , Wigle, Dennis A. , Prakash, Y. S. , Manlove, Logan, Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | November 15, 2014 | Volume: 308 | Issue: 2 | Pages: L141-L146

10.1152/ajplung.00266.2014 | PMID 25399436 Get It

Supplemental oxygen, used to treat hypoxia in preterm and term neonates, increases the risk of neonatal lung diseases, such as bronchopulmonary dysplasia (BPD) and asthma. There is a known sex predilection for BPD, but the underlying mechanisms are not clear. We tested the hypothesis that altered, local estradiol following hyperoxia contributes to pathophysiological changes observed in immature lung. In human fetal airway smooth muscle (fASM) cells exposed to normoxia or hyperoxia, we measured the expression of proteins involved in estrogen metabolism and cell proliferation responses to estradiol. In fASM cells, CYP1a1 expression was increased by hyperoxia, whereas hyperoxia-induced enhancement of cell proliferation was blunted by estradiol. Pharmacological studies indicated that these effects were attributable to upregulation of CYP1a1 and subsequent increased metabolism of estradiol to a downstream intermediate 2-methoxyestradiol. Microarray analysis of mouse lung exposed to 14 days of hyperoxia showed the most significant alteration in CYP1a1 expression, with minimal changes in expression of five other genes related to estrogen receptors, synthesis, and metabolism. Our novel results on estradiol metabolism in fetal and early postnatal lung in the context of hyperoxia indicate CYP1a1 as a potential mechanism for the protective effect of estradiol in hyperoxia-exposed immature lung, which may help explain the sex difference in neonatal lung diseases.
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary
Lacchetti, Christina , Loprinzi, Charles L. , Hershman, Dawn L.

Mayo Clinic

Journal of Oncology Practice | November 14, 2014 | Volume: 10 | Issue: 6 | Pages: e421-e424

10.1200/jop.2014.001776 | PMID 29424607 Get It

Pathogenic Ischemic Stroke Phenotypes in the NINDS-Stroke Genetics Network
Ay, Hakan , Arsava, Ethem Murat , Andsberg, Gunnar , Benner, Thomas, Brown, Robert D. , Chapman, Sherita , Delavaran, Hossein , Dichgans, Martin , Engström, Gunnar , Giralt‐Steinhauer, Eva , Grewal, Raji P., Gwinn, Katrina , Jiménez-Conde, Jordi , Katsnelson, Michael , Kissela, Brett , Kittner, Steven J. , Kleindorfer, Dawn , Labovitz, Daniel , Lanfranconi, Silvia , Lee, Jin‐Moo , Lehm, Manuel, Lemmens, Robin , Levi, Christopher , Li, Linxin , Lindgren, Arne, Markus, Hugh S. , McArdle, Patrick F. , Melander, Olle , Peddareddygari, Leema Reddy , Pedersén, Annie , Pera, Joanna , Rannikmäe, Kristiina , Rexrode, Kathryn M. , Rich, Stephen S. , Rothwell, Peter M. , Schmidt, Reinhold , Schürks, Markus , Seiler, Stephan , Słowik, Agnieszka , Sudlow, Cathie , Thijs, Vincent , Woodfield, Rebecca, Worrall, Bradford B. , Chapman, Sherita N, Cole, John W. , Giralt-Steinhauer, Eva, Jern, Christina, Jood, Katarina, Kleindorfer, Dawn O, Labovitz, Daniel L, Levi, Chris, Rhodes, David, Rundek, Tatjana , Slowik, Agnieszka, Jern, Christina , Jood, Katarina , Lindgren, Arne, Norrving, Bo , Rhodes, David , Roquer, Jaume , Rosand, Jonathan M. , Sacco, Ralph L. , Sharma, Pankaj Kumar , Meschia, James F. , Dichgans, Martin , Rich, Stephen S , Lemmens, Robin , Lee, Jin-Moo

Mayo Clinic

Stroke | November 7, 2014 | Volume: 45 | Issue: 12 | Pages: 3589-3596

10.1161/strokeaha.114.007362 | PMID 25378430 Get It

Background and Purpose— NINDS (National Institute of Neurological Disorders and Stroke)-SiGN (Stroke Genetics Network) is an international consortium of ischemic stroke studies that aims to generate high-quality phenotype data to identify the genetic basis of pathogenic stroke subtypes. This analysis characterizes the etiopathogenetic basis of ischemic stroke and reliability of stroke classification in the consortium. Methods— Fifty-two trained and certified adjudicators determined both phenotypic (abnormal test findings categorized in major pathogenic groups without weighting toward the most likely cause) and causative ischemic stroke subtypes in 16 954 subjects with imaging-confirmed ischemic stroke from 12 US studies and 11 studies from 8 European countries using the web-based Causative Classification of Stroke System. Classification reliability was assessed with blinded readjudication of 1509 randomly selected cases. Results— The distribution of pathogenic categories varied by study, age, sex, and race ( P <0.001 for each). Overall, only 40% to 54% of cases with a given major ischemic stroke pathogenesis (phenotypic subtype) were classified into the same final causative category with high confidence. There was good agreement for both causative (κ 0.72; 95% confidence interval, 0.69–0.75) and phenotypic classifications (κ 0.73; 95% confidence interval, 0.70–0.75). Conclusions— This study demonstrates that pathogenic subtypes can be determined with good reliability in studies that include investigators with different expertise and background, institutions with different stroke evaluation protocols and geographic location, and patient populations with different epidemiological characteristics. The discordance between phenotypic and causative stroke subtypes highlights the fact that the presence of an abnormality in a patient with stroke does not necessarily mean that it is the cause of stroke.
Health Care Outcomes and Advance Care Planning in Older Adults Who Receive Home-Based Palliative Care: A Pilot Cohort Study
Chen, Christina Y. , Cha, Stephen S., Hanson, Gregory J. , Rahman, Parvez, Naessens, James M. , Takahashi, Paul Y. , Thorsteinsdottir, Bjorg , Cha, Stephen S., Peterson, Stephanie M. Peck , Takahashi, Paul

Mayo Clinic

Journal of Palliative Medicine | November 6, 2014 | Volume: 18 | Issue: 1 | Pages: 38-44

10.1089/jpm.2014.0150 | PMID 25375663 Get It

Cigarette smoke enhances proliferation and extracellular matrix deposition by human fetal airway smooth muscle
Vogel, Elizabeth R. , VanOosten, Sarah Kay, Holman, Michelle A., Hohbein, Danielle D., Vassallo, Robert , Pandya, Hitesh , Prakash, Y. S. , VanOosten, Sarah K, Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Vassallo, Robert , Vogel, Elizabeth R

Mayo Clinic

American Journal of Physiology-Lung Cellular and Molecular Physiology | October 25, 2014 | Volume: 307 | Issue: 12 | Pages: L978-L986

10.1152/ajplung.00111.2014 | PMID 25344066 Get It

Cigarette smoke is a common environmental insult associated with increased risk of developing airway diseases such as wheezing and asthma in neonates and children. In adults, asthma involves airway remodeling characterized by increased airway smooth muscle (ASM) cell proliferation and increased extracellular matrix (ECM) deposition, as well as airway hyperreactivity. The effects of cigarette smoke on remodeling and contractility in the developing airway are not well-elucidated. In this study, we used canalicular-stage (18–20 wk gestational age) human fetal airway smooth muscle (fASM) cells as an in vitro model of the immature airway. fASM cells were exposed to cigarette smoke extract (CSE; 0.5–1.5% for 24–72 h), and cell proliferation, ECM deposition, and intracellular calcium ([Ca 2+ ] i ) responses to agonist (histamine 10 μM) were used to evaluate effects on remodeling and hyperreactivity. CSE significantly increased cell proliferation and deposition of ECM molecules collagen I, collagen III, and fibronectin. In contrast, [Ca 2+ ] i responses were not significantly affected by CSE. Analysis of key signaling pathways demonstrated significant increase in extracellular signal-related kinase (ERK) and p38 activation with CSE. Inhibition of ERK or p38 signaling prevented CSE-mediated changes in proliferation, whereas only ERK inhibition attenuated the CSE-mediated increase in ECM deposition. Overall, these results demonstrate that cigarette smoke may enhance remodeling in developing human ASM through hyperplasia and ECM production, thus contributing to development of neonatal and pediatric airway disease.
Overestimation of Glomerular Filtration Rate Among Critically Ill Adults With Hospital-Acquired Oligoanuric Acute Kidney Injury
Frazee, Erin N., Personett, Heather A. , Wood‐Wentz, Christina M. , Herasevich, Vitaly , Frazee, Erin N., Lieske, John C. , Kashani, Kianoush , Herasevich, Vitaly

Mayo Clinic

Journal of Pharmacy Practice | October 18, 2014 | Volume: 29 | Issue: 2 | Pages: 125-131

10.1177/0897190014549841 | PMID 25326198 Get It

Background: Medication use in the intensive care unit (ICU) depends on creatinine-based glomerular filtration rate (GFR) estimates. Urine output deterioration may precede the creatinine rise resulting in delayed recognition of GFR reductions. Our objective was to quantify the disparity between estimated GFR (eGFR) and true GFR in ICU patients with hospital-acquired oligoanuric acute kidney injury (hAKI). Methods: This single-center cohort study examined adults who met the Acute Kidney Injury Network stage III urine output criterion ≥48 hours after ICU admission. True GFR was ≤15 mL/min/1.73 m 2 , and eGFR was described by 6 different creatinine-based equations. True GFR and eGFR were compared on the day of hAKI diagnosis and followed for 4 days using multivariable linear regression with generalized estimating equations, adjusting for day and method. Results: Of the 691 patients screened, we enrolled 61 patients. After adjustment for multiple comparisons and day, there were significant differences in eGFR between the estimation methods and true GFR ( P < .001). After day adjustment, eGFR overestimated true GFR by 17 to 50 mL/min/1.73 m 2 and overestimation persisted through the fourth day of hAKI ( P ≤ .001). Conclusion: Creatinine-based equations overestimated GFR in ICU patients with hAKI. This study highlights a population at risk of medication misadventures in whom systems optimization should be considered.
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis
Sundal, Christina , Baker, Matt , Karrenbauer, Virginija Danylaité , Gustavsen, Marte W., Bedri, Sahl Khalid , Glaser, Anna , Myhr, K-M, Haugarvoll, Kristoffer , Harbo, Hanne F. , Kockum, Ingrid , Rademakers, Rosa , Andersen, O., Zetterberg, Henrik , Hillert, Jan A. , Wszołek, Zbigniew K. , Danylaité Karrenbauer, Virginija

Mayo Clinic

European Journal of Neurology | October 13, 2014 | Volume: 22 | Issue: 2 | Pages: 328-333

10.1111/ene.12572 | PMID 25311247 Get It

Background and purposeHereditary diffuse leukoencephalopathy with spheroids (HDLS) is a devastating, hereditary white matter (WM) disorder with heterogeneous neuropsychiatric features. Colony stimulating factor 1 receptor (CSF1R) mutations were looked for in primary progressive multiple sclerosis (PPMS) patients and the clinical features of a family with a novel CSF1R mutation are reported.MethodsCSF1R exons 12−22 in a cohort of 220 PPMS patients from the Swedish and Norwegian national multiple sclerosis registries were sequenced.ResultsOne patient had a novel mutation, c.2562T>A; p.Asn854Lys, in the CSF1R gene. Her symptoms started at the age of 29 years with insidious onset of pyramidal weakness in the left leg. The cerebrospinal fluid examination showed four intrathecal immunoglobulin G bands. A magnetic resonance imaging scan performed 4 years after symptom onset demonstrated patchy deep WM lesions. She was diagnosed as having PPMS and treated with intramuscular interferon beta 1a. Due to slow disease progression, the development of memory decline and cerebellar signs, she was given subcutaneous interferon beta 1a without any benefit. The updated pedigree indicated that five siblings also had the CSF1R gene mutation; one was diagnosed with PPMS. Six more distant relatives also had a neurological disorder; four were clinically diagnosed with PPMS.ConclusionsOur study indicates that a chronic course of HDLS may mimic PPMS. Genetic testing for CSF1R gene mutations in PPMS cases with a positive family history of neurological disorders may establish the diagnosis of HDLS.
Casp8p41 generated by HIV protease kills CD4 T cells through direct Bak activation
Sainski, Amy M., Dai, Haiming , Natesampillai, Sekar, Pang, Yuan‐Ping , Bren, Gary D., Correia, Cristina , Meng, X. Wei, Tarara, James E., Ramı́rez-Alvarado, Marina , Katzmann, David J. , Ochsenbauer, Christina , Kappes, John C. , Kaufmann, Scott H. , Badley, Andrew D. , Ramirez-Alvarado, Marina, Cummins, Nathan W. , Kaufmann, Scott H , Correia, Cristina , Ramirez-Alvarado, Marina , Badley, Andrew D , Pang, Yuan-Ping , Dai, Haiming

Mayo Clinic

Journal of Cell Biology | September 23, 2014 | Volume: 206 | Issue: 7 | Pages: 867-876

10.1083/jcb.201405051 | PMID 25246614 Get It

Previous studies have shown that human immunodeficiency virus (HIV) protease cleaves procaspase 8 to a fragment, termed Casp8p41, that lacks caspase activity but nonetheless contributes to T cell apoptosis. Herein, we show that Casp8p41 contains a domain that interacts with the BH3-binding groove of pro-apoptotic Bak to cause Bak oligomerization, Bak-mediated membrane permeabilization, and cell death. Levels of active Bak are higher in HIV-infected T cells that express Casp8p41. Conversely, targeted mutations in the Bak-interacting domain diminish Bak binding and Casp8p41-mediated cell death. Similar mutations in procaspase 8 impair the ability of HIV to kill infected T cells. These observations support a novel paradigm in which HIV converts a normal cellular constituent into a direct activator that functions like a BH3-only protein.